Bansil S, Singhal B S, Ahuja G K, Ladiwala U, Behari M, Friede R, Cook S D
Department of Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.
Neurology. 1996 Feb;46(2):385-7. doi: 10.1212/wnl.46.2.385.
The prevalence of MS in India is low, and it is unclear whether the manifestations of the disease in India are similar to the United States. We carried out a case-control study to compare the disease in the two populations and used clinical, evoked potential, and MRI criteria to assess similarities and differences. Our results indicate that the rate of disease progression and frequency of involvement of the cerebral hemispheres, cerebellum, spinal cord, and brainstem were similar in the two populations. The visual system was more frequently involved in Indian patients. No Indian patient had a family history of MS; this suggests an environmental disease-triggering agent.
多发性硬化症在印度的患病率较低,且该疾病在印度的表现是否与美国相似尚不清楚。我们开展了一项病例对照研究,以比较这两个人群中的该疾病,并使用临床、诱发电位和磁共振成像标准来评估异同。我们的结果表明,两个人群中疾病的进展速度以及大脑半球、小脑、脊髓和脑干受累的频率相似。印度患者的视觉系统受累更为频繁。没有印度患者有多发性硬化症家族史;这表明存在一种环境致病因素。